72: Should We All Switch To Bivalirudin? ED ECMO podcast

Artwork

Science Fitness Medicine Scott Weingart the EDECMO Hosts - Drs. Joe Bellezzo Zack Shinar

Indhold leveret af Zack Shinar, MD, Zack Shinar, and MD. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Zack Shinar, MD, Zack Shinar, and MD eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

ED ECMO « »
72: Should We All Switch To Bivalirudin?

3+ y ago 29:39

Del

MP3•Episode hjem

Indhold leveret af Zack Shinar, MD, Zack Shinar, and MD. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Zack Shinar, MD, Zack Shinar, and MD eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Heparin has been the mainstay of anticoagulation for ECMO patients for years. In recent years, this has been challenged. Bivalirudin has b ecome a potential better anticoagulant. Troy Seelhammer in EDECMO episode 55 gave us some insight into this. This month Ryan Rivosecchi and his crew at UPitt have released their findings in Critical Care Medicine. This retrospective study suggests great improvement in major bleeding in patients who received Bivalirudin compare to Heparin (40.7% vs 11.7%, p < 0.001). Listen to Ryan and Zack discuss anticoagulant use in ECMO patients in this month's episode. Rivosecchi RM, Arakelians AR, Ryan J, Murray H, Padmanabhan R, Gomez H, Phillips D, Sciortino C, Arlia P, Freeman D, Sappington PL, Sanchez PG. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin. Crit Care Med. 2021 Mar 15. doi: 10.1097/CCM.0000000000004944. Epub ahead of print. PMID: 33711003. .

… continue reading

104 episoder

#Science #Fitness #Medicine #Scott Weingart #the EDECMO Hosts - Drs. Joe Bellezzo #Zack Shinar

Artwork

72: Should We All Switch To Bivalirudin?

published 3+ y ago

Del

MP3•Episode hjem

Indhold leveret af Zack Shinar, MD, Zack Shinar, and MD. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Zack Shinar, MD, Zack Shinar, and MD eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

Heparin has been the mainstay of anticoagulation for ECMO patients for years. In recent years, this has been challenged. Bivalirudin has b ecome a potential better anticoagulant. Troy Seelhammer in EDECMO episode 55 gave us some insight into this. This month Ryan Rivosecchi and his crew at UPitt have released their findings in Critical Care Medicine. This retrospective study suggests great improvement in major bleeding in patients who received Bivalirudin compare to Heparin (40.7% vs 11.7%, p < 0.001). Listen to Ryan and Zack discuss anticoagulant use in ECMO patients in this month's episode. Rivosecchi RM, Arakelians AR, Ryan J, Murray H, Padmanabhan R, Gomez H, Phillips D, Sciortino C, Arlia P, Freeman D, Sappington PL, Sanchez PG. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin. Crit Care Med. 2021 Mar 15. doi: 10.1097/CCM.0000000000004944. Epub ahead of print. PMID: 33711003. .

… continue reading

104 episoder

#Science #Fitness #Medicine #Scott Weingart #the EDECMO Hosts - Drs. Joe Bellezzo #Zack Shinar

همه قسمت ها

×

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

Lyt til 500+ emner